Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · IEX Real-Time Price · USD
3.200
+0.020 (0.63%)
May 3, 2024, 4:00 PM EDT - Market closed

RVPH Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
8911787404586
Market Cap Growth
-34.26%115.01%-9.83%-48.16%-
Enterprise Value
669368113690
PE Ratio
-2.97-2.97-3.07-4.74-11.84-102.09
PB Ratio
15.6220.4010.351.418.20-12.69
P/FCF Ratio
-4.12-4.12-4.58-3.79-11.02-395.77
P/OCF Ratio
-4.12-4.12-4.58-3.79-11.02-395.77
EV/EBITDA Ratio
-2.38-2.38-2.42-1.26-15.48-239.93
EV/EBIT Ratio
-2.38-2.38-2.42-1.26-15.48-239.52
EV/FCF Ratio
-3.29-3.29-3.61-1.00-8.87-413.00
Debt / Equity Ratio
------0.55
Debt / EBITDA Ratio
------10.01
Debt / FCF Ratio
------17.24
Quick Ratio
1.361.361.8612.666.57-
Interest Coverage
-----1.60-0.80
Return on Equity (ROE)
-3410.00%-3410.00%-170.80%-34.10%562.30%-
Return on Assets (ROA)
-291.70%-291.70%-127.20%-31.40%-86.30%-
Return on Capital (ROIC)
-690.78%-690.78%-336.29%-35.22%-44.54%12.37%
Earnings Yield
-43.95%-33.66%-32.53%-21.09%-8.44%-0.98%
FCF Yield
-31.70%-24.28%-21.82%-26.40%-9.07%-0.25%
Buyback Yield / Dilution
-21.94%-21.94%-31.95%-383.10%-10.60%-
Total Shareholder Return
-21.94%-21.94%-31.95%-383.10%-10.60%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).